| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000004165 |
| Receipt No. | R000005002 |
| Official scientific title of the study | Trial of fetoscopic laser surgery for twin amniotic fluid discordance |
| Date of disclosure of the study information | 2010/09/09 |
| Last modified on | 2017/09/11 (Ver. 8) |
| Basic information | ||
| Official scientific title of the study | Trial of fetoscopic laser surgery for twin amniotic fluid discordance | |
| Title of the study (Brief title) | Fetoscopic laser surgery for TAFD | |
| Region |
|
|
| Condition | |||
| Condition | Twin Amniotic Fluid Discordance; TAFD | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | To evaluate the safety of fetoscopic laser surgery for the monochorionic twin pregnancy with both the discordance of amniotic fluid between the twins and abnormal Doppler findings. |
| Basic objectives2 | Safety |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Completion of laser surgery and safety for pregnant women |
| Key secondary outcomes | Improvement of TAFD at 14 days after surgery, incidence of TTTS at 14 days after surgery, Complications of laser surgery until 14days after laser surgery |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Fetsocopic laser surgery is performed according to the procedure for twin to twin transfusion syndrome.
The anastomoses between the twins are coagulated by laser under fetoscopy through the maternal abdomen. The lactolinger is infused into the amniotic cavity if necessary. The amniotic fluid is aspirated at the end of the surgery. |
|
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Female | |||
| Key inclusion criteria | 1) Between 20 weeks and 24 weeks 6 days gestation
2) Monochorionic diamniotic twin pregnancy 3) Ultrasound findings within four days before surgery meet the criteria as following a) not TTTS (Maximal vertical pocket (MVP) between 2cm and 8cm) b) MVP blow 3cm in one twin, and MVP more than 7cm in the other twin c) Presence of abnormal Doppler study in either twin 4) No history of amnioreduction 5) No presence of fetal anomalies 6) No sign of pregnancy induced hypertension 7) No genital bleeding 8) No premature rupture of membrane 9) Cervical length more than 20mm |
|||
| Key exclusion criteria | 1) Distance between expected insertion site of fetoscopy and the edge of placenta is below 1 cm.
2) Pregnant woman needs treatment for infectious disease. 3) Presence of HIV antibody, HCV antibody, or HBe antigen in pregnant women 4) Pregnant woman needs treatment for psychological problems 5) American Society of Anesthesiology (ASA) Physical Status Classification: Class 3, 4, 5, or 6 |
|||
| Target sample size | 10 | |||
| Research contact person | |
| Name of lead principal investigator | Haruhiko Sago MD PhD |
| Organization | National Center for Child Health and Development |
| Division name | Department of Maternal-Fetal and Neonatal Medicine |
| Address | 2-10-1 Okura, Setagaya-ku, Tokyo 157-8535, Japan |
| TEL | 03-3416-0181 |
| sagou-h@ncchd.go.jp | |
| Public contact | |
| Name of contact person | Haruhiko Sago MD PhD |
| Organization | National Center for Child Health and Development |
| Division name | Division of Fetal Medicine, Department of Maternal-Fetal and Neonatal Medicine |
| Address | 2-10-1 Okura, Setagaya-ku, Tokyo 157-8535, Japan |
| TEL | 03-3416-0181 |
| Homepage URL | |
| sagou-h@ncchd.go.jp | |
| Sponsor | |
| Institute | Japan Fetal Therapy Group (Fetusjapan) |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Ministry of Health, Labour and Welfare |
| Organization | |
| Division | |
| Category of Funding Organization | Japanese Governmental office |
| Nationality of Funding Organization | Japan |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Published |
| URL releasing results | |
| Results | A total of 11 cases were enrolled.
FLP was completed in all cases. There were no severe FLP-related maternal complications. Among 11 donor twins, 3 survived, 7 died in utero, and 1 died in the neonatal period (survival rate: 27.3%). All of the recipient twins survived (survival rate: 100%). |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000005002 |